• SP1/ADAM10/DRP1 Signaling in Hypoxic Pulmonary Hypertension

  2026-09-07

  The reference study identifies an SP1/ADAM10/DRP1 signaling axis that connects hypoxia-stressed endothelial cells with pulmonary artery smooth muscle cells in hypoxia pulmonary hypertension. Its conditioned-medium experiments and pharmacological inhibition data suggest that endothelial ADAM10 promotes a proliferative, apoptosis-resistant smooth muscle phenotype through DRP1 and PI3K/AKT/mTOR signaling.

• Ibotenic Acid: An NMDA Receptor Agonist for Translation

  2026-09-07

  Ibotenic acid is more than a neuroactive reagent: it is a strategically useful perturbation tool for connecting glutamatergic signaling, neuronal injury, and translational model design. This thought-leadership guide interprets recent dose- and time-dependent mouse toxicity findings and translates them into practical considerations for reproducible neuroscience research.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-09-05

  The reference study identifies a previously unrecognized maintenance mechanism in which social interaction triggers secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus. Its intracellular NLG1-CTD fragment connects PDZ-domain signaling, cofilin regulation, dendritic spine strengthening, and persistence of social memory.

• Capecitabine in Patient-Derived Tumor Assembloids

  2026-09-04

  Learn how Capecitabine can be evaluated in matched tumor organoid and stromal assembloid systems rather than simplified monocultures. This workflow combines activation-aware dosing, microenvironment comparisons, and practical troubleshooting for more informative preclinical oncology research.

• Podophyllotoxin Workflows for Cancer Cell Research

  2026-09-04

  Build reproducible Podophyllotoxin experiments around solubility-aware dosing, cell-cycle profiling, apoptosis assays, and autophagy validation. A reference-led comparison with derivative 5p helps distinguish the parent compound’s microtubule activity from newer multidrug-resistance strategies.

• Amiloride (MK-870) Beyond Sodium Channels

  2026-09-03

  Amiloride (MK-870) is more than an epithelial sodium channel tool: its negative result in a grass carp reovirus entry study illustrates how to interpret pharmacological controls. This guide connects sodium channel research, endocytosis assay design, and disease-model applications without conflating distinct mechanisms.

• TRPM3 Regulation by Neurosteroids and Primidone

  2026-09-03

  The reference study defines how neurosteroids, synthetic agonists, and Primidone regulate the TRPM3 calcium-permeable channel using cryo-electron microscopy, electrophysiology, and molecular dynamics. Its structures connect ligand binding with channel gating and provide a mechanistic framework for TRPM3 channel inhibition in neurodevelopmental disorders, pain, and future drug development.

• DrPISA Expands Proteomic Drug-Target Discovery

  2026-09-02

  The 2026 DrPISA study introduces a deep eutectic solvent-assisted reverse PISA workflow that recovers heat-aggregated proteins usually missed by soluble-proteome assays. By improving aggregate resolubilization, digestion, and quantitative mass spectrometry efficiency, the method increases sensitivity for subtle drug-induced stability changes and reveals previously overlooked interactions such as the celastrol–LULL1 association.

• Broad-Spectrum Bivalent mRNA Vaccine Study

  2026-09-02

  The reference study characterizes RQ3025, a bivalent mRNA vaccine designed around shared SARS-CoV-2 spike mutations, and reports broad neutralizing activity across animal models. Its findings support variant-aware antigen design while underscoring the need to distinguish preclinical immunogenicity and protection from demonstrated human clinical benefit.

• SW033291: 15-PGDH Inhibitor Workflows

  2026-09-01

  SW033291 is a nanomolar 15-PGDH inhibitor for connecting prostaglandin E2 elevation with hematopoiesis, stem-cell behavior, and tissue repair. This practical guide translates its biochemical and cellular activity into assay workflows, combination studies, and troubleshooting strategies for regeneration research.

• JXE-23 in HCC: Growth, Arrest, and Protective Autophagy

  2026-09-01

  This 2024 study identifies the fern-derived diterpene JXE-23 as a selective inhibitor of HepG2 hepatocellular carcinoma cell growth and links its activity to G2/M arrest, migration suppression, and CIP2A/p-AKT/c-Myc pathway inactivation. Its most important mechanistic contribution is the demonstration that JXE-23 induces protective rather than cytotoxic autophagy, suggesting that autophagy inhibition may improve its anticancer effect.

• DMXAA (Vadimezan) Workflow for Tumor-Vascular Assays

  2026-08-31

  Build mechanism-resolved tumor-vascular assays with DMXAA (Vadimezan), linking endothelial injury, VEGFR2-related signaling, apoptosis, and tumor-cell responses. This workflow also shows how to distinguish vascular disruption from vessel normalization when interpreting immune-context experiments.

• Luminescent ATP Detection Assay Kit for Colitis

  2026-08-31

  The Luminescent ATP Detection Assay Kit converts cellular and tissue energy status into a sensitive, plate-based luminescence readout. In ulcerative colitis research, it can complement NOX2/ROS/mitochondrial studies by testing whether an intervention preserves ATP alongside inflammation, barrier injury, and tissue pathology.

• v-Agatoxin-IVA and N-Type Ca Channel Blockade

  2026-08-30

  Sidach and Mintz showed that v-Agatoxin-IVA is a selective high-affinity blocker of P-type calcium channels but can also produce weaker, voltage-dependent inhibition of native N-type currents at micromolar exposure. The study refined pharmacological classification of neuronal calcium channels and cautioned against using v-Aga-IVA alone to identify Q-type currents.

• Cy5.5 NHS Ester for Piezo-Nanoplatform Imaging

  2026-08-29

  Cy5.5 NHS ester enables covalent near-infrared tracking of amine-bearing proteins, peptides, oligonucleotides, and biomimetic nanoplatforms. This workflow translates an ultrasound-responsive epilepsy treatment concept into practical biodistribution, localization, and assay-control strategies while addressing the dye’s low aqueous solubility.

7891 records 1/527 page Next 12345 下5页 Last page